CAD 0.07
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -449.15 Thousand CAD | -145.61% |
2022 | 984.82 Thousand CAD | -57.74% |
2021 | 2.33 Million CAD | 511.96% |
2020 | -565.75 Thousand CAD | 86.83% |
2019 | -4.29 Million CAD | -412.89% |
2018 | -837.6 Thousand CAD | -349.6% |
2017 | -186.3 Thousand CAD | -52.87% |
2016 | -121.86 Thousand CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -412.86 Thousand CAD | -719.42% |
2024 Q1 | 66.65 Thousand CAD | 114.84% |
2024 Q3 | -246.57 Thousand CAD | 40.28% |
2023 Q4 | -449.15 Thousand CAD | -129.14% |
2023 Q3 | -196.01 Thousand CAD | -217.97% |
2023 FY | -449.15 Thousand CAD | -145.61% |
2023 Q1 | 945.07 Thousand CAD | -4.04% |
2023 Q2 | 166.16 Thousand CAD | -82.42% |
2022 FY | 984.82 Thousand CAD | -57.74% |
2022 Q3 | 895.95 Thousand CAD | 56.27% |
2022 Q2 | 573.32 Thousand CAD | 2172.68% |
2022 Q1 | 25.22 Thousand CAD | -98.92% |
2022 Q4 | 984.82 Thousand CAD | 9.92% |
2021 Q4 | 2.33 Million CAD | 122.03% |
2021 Q3 | 1.04 Million CAD | 432.17% |
2021 Q2 | -316.02 Thousand CAD | -371.73% |
2021 FY | 2.33 Million CAD | 511.96% |
2021 Q1 | 116.29 Thousand CAD | 120.56% |
2020 Q3 | -1.69 Million CAD | -184.57% |
2020 FY | -565.75 Thousand CAD | 86.83% |
2020 Q4 | -565.75 Thousand CAD | 66.71% |
2020 Q2 | -597.26 Thousand CAD | 67.22% |
2020 Q1 | -1.82 Million CAD | 57.59% |
2019 Q4 | -4.29 Million CAD | 21.75% |
2019 Q3 | -5.49 Million CAD | -54.36% |
2019 Q2 | -3.55 Million CAD | -4104.91% |
2019 Q1 | -84.58 Thousand CAD | 43.34% |
2019 FY | -4.29 Million CAD | -412.89% |
2018 Q1 | 342.57 Thousand CAD | 190.1% |
2018 Q2 | -188.76 Thousand CAD | -155.1% |
2018 Q3 | -167.74 Thousand CAD | 11.13% |
2018 Q4 | -149.29 Thousand CAD | 11.0% |
2018 FY | -837.6 Thousand CAD | -349.6% |
2017 Q3 | -103.5 Thousand CAD | 0.0% |
2017 FY | -186.3 Thousand CAD | -52.87% |
2017 Q4 | -380.22 Thousand CAD | -267.36% |
2016 FY | -121.86 Thousand CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aion Therapeutic Inc. | 826.13 Thousand CAD | 154.368% |
Ayurcann Holdings Corp. | 69.97 Thousand CAD | 741.84% |
Blueberries Medical Corp. | -805.35 Thousand CAD | 44.229% |
The BC Bud Corporation | 225.15 Thousand CAD | 299.488% |
BioNxt Solutions Inc. | 4.53 Million CAD | 109.914% |
CordovaCann Corp. | 6.13 Million CAD | 107.326% |
Christina Lake Cannabis Corp. | 4.62 Million CAD | 109.705% |
Captor Capital Corp. | -5.41 Million CAD | 91.699% |
City View Green Holdings Inc. | 1.49 Million CAD | 129.979% |
1CM Inc. | 3.31 Million CAD | 113.549% |
Global Hemp Group Inc. | 3.55 Million CAD | 112.645% |
Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | 103.1% |
IM Cannabis Corp. | 11.96 Million CAD | 103.753% |
Lobe Sciences Ltd. | 192.35 Thousand CAD | 333.508% |
Maple Leaf Green World Inc. | 2.47 Million CAD | 118.156% |
Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 92.407% |
Ovation Science Inc. | 143.76 Thousand CAD | 412.419% |
Pharmadrug Inc. | 1.2 Million CAD | 137.222% |
Captiva Verde Wellness Corp. | 186.26 Thousand CAD | 341.143% |
RAMM Pharma Corp. | -4.71 Million CAD | 90.467% |
RIV Capital Inc. | -101.38 Million CAD | 99.557% |
Revive Therapeutics Ltd. | -797.85 Thousand CAD | 43.705% |
Red White & Bloom Brands Inc. | 259.87 Million CAD | 100.173% |
SLANG Worldwide Inc. | 20.83 Million CAD | 102.156% |
1933 Industries Inc. | 16.47 Million CAD | 102.726% |
Red Light Holland Corp. | -13.56 Million CAD | 96.688% |
Top Strike Resources Corp. | 13.24 Million CAD | 103.39% |
Xebra Brands Ltd. | -102.41 Thousand CAD | -338.549% |
Adastra Holdings Ltd. | 2.2 Million CAD | 120.376% |